Results 31 to 40 of about 2,820,921 (304)

Effective Administration of Rituximab in Anti-MDA5 Antibody–Positive Dermatomyositis with Rapidly Progressive Interstitial Lung Disease and Refractory Cutaneous Involvement: A Case Report and Literature Review

open access: yesCase Reports in Rheumatology, 2017
We describe the case of a 48-year-old man with dermatomyositis (DM) who demonstrated rapidly progressive interstitial lung disease (RP-ILD) and refractory cutaneous involvement together with high levels of anti-melanoma differentiation-associated gene 5 ...
Yuka Ogawa   +4 more
semanticscholar   +1 more source

Excitation of cutaneous C nociceptors by intraplantar administration of anandamide [PDF]

open access: yesBrain Research, 2009
Anandamide has been characterized as both an endocannabinoid and endovanilloid. Consistent with its actions as an endovanilloid, previous studies have demonstrated that anandamide can excite primary sensory neurons in vitro via transient receptor potential vanilloid type one (TRPV1) receptors.
Carl, Potenzieri   +2 more
openaire   +2 more sources

Successful outcome of mucormycosis in two children on induction therapy for acute lymphoblastic leukemia

open access: yesIndian Journal of Medical and Paediatric Oncology, 2013
Zygomycetes are one of the less common causes of invasive fungal infections in patients with the hematological malignancies. We report two cases of acute lymphoblastic leukemia in the pediatric age group, complicated by disseminated cutaneous ...
Anshul Gupta   +3 more
doaj   +1 more source

Polymeric Microneedles for Transdermal Delivery of Rivastigmine: Design and Application in Skin Mimetic Model

open access: yesPharmaceutics, 2022
In the last years, microneedles (MNs) have been considered a valuable, painless, and minimally invasive approach for controlled transdermal drug delivery (TDD).
Tânia M. T. Guimarães   +8 more
doaj   +1 more source

CUTANEOUS ADMINISTRATION OF SALICYLATES IN RHEUMATISM, GOUT, ETC. [PDF]

open access: yesJAMA: The Journal of the American Medical Association, 1898
Dr. Edmund L. Gross of Paris, in a recently published brochure, presents several new ideas. He says that though the various affections classed under gouty or rheumatic often differ widely as to their manifestations, they incontestably possess numerous traits in common.
openaire   +1 more source

Mogamulizumab Efficacy is Underscored by its Associated Rash that Mimics Cutaneous T-cell Lymphoma: A Retrospective Single-Centre Case Series

open access: yesBritish Journal of Dermatology, 2021
Mogamulizumab is a humanized antibody against chemokine receptor type 4. It was recently approved by the US Food and Drug Administration for relapsed or refractory mycosis fungoides (MF) and Sézary syndrome (SS).
N. Trum   +9 more
semanticscholar   +1 more source

On the Development of a Cutaneous Flavonoid Delivery System: Advances and Limitations

open access: yesAntioxidants, 2021
Flavonoids are one of the vital classes of natural polyphenolic compounds abundantly found in plants. Due to their wide range of therapeutic properties, which include antioxidant, anti-inflammatory, photoprotective, and depigmentation effects, flavonoids
R. Costa   +3 more
semanticscholar   +1 more source

Cross-linked chitosan/lysozyme hydrogels with inherent antibacterial activity and tuneable drug release properties for cutaneous drug administration

open access: yesScience and Technology of Advanced Materials, 2023
Gels with high drug release sustainability and intrinsic antibacterial properties are of high practical potential for cutaneous drug administration, particularly for wound care and skin disease treatment.
Wing-Fu Lai   +4 more
doaj   +1 more source

Progression of Cutaneous T-Cell Lymphoma after dupilumab: Case review of 7 patients

open access: yesJournal of American Academy of Dermatology, 2020
Dupilumab is a fully human monoclonal antibody that binds the interleukin-4 receptor alpha (IL-4R) subunit and inhibits signaling of IL-4 and IL-13.
M. Espinosa   +12 more
semanticscholar   +1 more source

Cutaneous adverse reactions after COVID‐19 vaccines in a cohort of 2740 Italian subjects: An observational study

open access: yesDermatologic Therapy, 2021
An in‐depth characterization of the incidence, morphology, and onset of COVID‐19‐vaccines cutaneous adverse reactions is currently lacking. The existing literature on COVID‐19 vaccination‐related cutaneous adverse reactions largely focused on messenger ...
T. Grieco   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy